NovoCure Ltd. (NVCR)
10.89
-0.25
(-2.24%)
USD |
NASDAQ |
Nov 18, 10:41
NovoCure Shareholders Equity (Quarterly) : 350.61M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 350.61M |
| June 30, 2026 | 338.09M |
| March 31, 2026 | 330.72M |
| December 31, 2025 | 340.47M |
| September 30, 2025 | 341.33M |
| June 30, 2025 | 349.44M |
| March 31, 2025 | 361.96M |
| December 31, 2024 | 360.18M |
| September 30, 2024 | 360.78M |
| June 30, 2024 | 361.75M |
| March 31, 2024 | 359.36M |
| December 31, 2023 | 362.50M |
| September 30, 2023 | 393.70M |
| June 30, 2023 | 415.68M |
| March 31, 2023 | 432.15M |
| December 31, 2022 | 441.17M |
| September 30, 2022 | 445.40M |
| June 30, 2022 | 441.67M |
| March 31, 2022 | 435.88M |
| December 31, 2021 | 410.49M |
| September 30, 2021 | 413.16M |
| June 30, 2021 | 397.27M |
| March 31, 2021 | 372.13M |
| December 31, 2020 | 476.53M |
| Date | Value |
|---|---|
| September 30, 2020 | 307.04M |
| June 30, 2020 | 267.82M |
| March 31, 2020 | 241.95M |
| December 31, 2019 | 217.79M |
| September 30, 2019 | 190.36M |
| June 30, 2019 | 158.91M |
| March 31, 2019 | 126.39M |
| December 31, 2018 | 112.26M |
| September 30, 2018 | 114.94M |
| June 30, 2018 | 112.08M |
| March 31, 2018 | 106.12M |
| December 31, 2017 | 113.56M |
| September 30, 2017 | 116.68M |
| June 30, 2017 | 117.54M |
| March 31, 2017 | 128.90M |
| December 31, 2016 | 142.34M |
| September 30, 2016 | 158.24M |
| June 30, 2016 | 186.65M |
| March 31, 2016 | 220.43M |
| December 31, 2015 | 250.82M |
| September 30, 2015 | 121.22M |
| June 30, 2015 | 144.31M |
| March 31, 2015 | 76.42M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| LivaNova Plc | 1.372B |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
| Polarean Imaging Plc | -- |
| Accuray, Inc. | 53.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 828.71M |
| Total Liabilities (Quarterly) | 478.10M |
| Debt to Equity Ratio | 0.6604 |
| Current Ratio | 2.488 |
| Net Debt Paydown Yield | 5.03% |